Literature DB >> 18623862

Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

.   

Abstract

Entities:  

Year:  1961        PMID： 18623862      PMCID： PMC1007231          DOI： 10.1136/ard.20.4.315

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  A controlled trial of phenylbutazone, oxyphenbutazone, and a placebo in the treatment of rheumatoid arthritis.

Authors:  R I MEANOCK; E LEWIS-FANING
Journal:  Ann Rheum Dis       Date:  1961-06       Impact factor: 19.103
  1 in total
  41 in total

1.  In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

Authors:  R J Rooney; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 2.  Medical management of children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

3.  Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.

Authors:  M Farr; G Kitas; P A Bacon
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

4.  An European open multicentre trial with auranofin in rheumatoid arthritis.

Authors:  F Raeman; F Hanssens; M Delattre
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 5.  Nanotechnologies for noninvasive measurement of drug release.

Authors:  Thomas Moore; Hongyu Chen; Rachel Morrison; Fenglin Wang; Jeffrey N Anker; Frank Alexis
Journal:  Mol Pharm       Date:  2013-11-26       Impact factor: 4.939

6.  Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.

Authors:  P E Prete; J Zane; M Krailo; M Bulanowski
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

7.  Longterm experience with oral gold in rheumatoid arthritis and psoriatic arthritis.

Authors:  J Dequeker; W Verdickt; G Gevers; K Vanschoubroek
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

8.  Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin.

Authors:  P Franchimont; C Hauwaert; K Vanschoubroek
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.

Authors:  R J Coughlan; M B Richter; G S Panayi
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

10.  The assessment of radiological changes in the hands and wrists in rheumatoid arthritis.

Authors:  K A Grindulis; D L Scott; G R Struthers
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.